729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis

Melinda Gooderham, David Rosmarin, Maryam Shayesteh Alam et al.|British Journal of Dermatology|2024

Cited by 2